John Fatterman will be Miss PA Primary Night’s party when he recovers from a stroke – NBC10 Philadelphia

John Fetterman, the lieutenant governor of Pennsylvania and the main candidate for the U.S. Senate from the Democratic Party, withdrew from the election campaign in the critical last hours before the primaries. recovers after stroke he said it was caused by a heart disease called atrial fibrillation.

In a Sunday statement, Fetterman said doctors believe he is on his way to “full recovery.” But it was unclear how much he would need to rest and recover.

Then on Monday his campaign said Fetterman would not attend the party before Tuesday’s election.

Here’s a look at what happened, the diagnosis, the future of the Fetterman campaign and what could cause A-fib.

Pennsylvania Lt. Gov. and U.S. Senate Democratic nominee John Fetterman was hospitalized after a stroke, causing his campaign to be suspended ahead of Tuesday’s primaries. Lauren Mike of NBC10 has the details and looks at the latest push of the other candidates ’campaign.

What happened?

It was Friday morning when Fetherman’s company first canceled the event. The company’s communications director, Joe Calvela, told many people who were waiting for a meeting with Fetterman at the University of Millersville that he felt bad that morning and had to cancel.

The company canceled other events on Friday and the weekend, without saying anything about its condition and location. They are discovered Sunday afternoon that 52-year-old Democrat suffered a stroke and was hospitalized at Penn Medicine Lancaster General Hospital.

After 16 seconds video published by the company with a statement, Feterman and his wife Giselle appear together, while Feterman sits and speaks clearly.

“As you can see, we made a small mistake in the election campaign,” she began.

Will this affect Fetherman’s campaign?

The 52-year-old Fetterman claims that his candidacy will continue, that he is feeling much better and that he is expected to fully recover.

However, on Monday morning, his company said it was not expected to leave hospital in Lancaster in time to attend the main night event his company had scheduled for Pittsburgh on Tuesday.

“The show will continue,” Fetterman’s e-mail said. Pennsylvania’s second lady Gisele Fetterman and “special guests” will be present Tuesday night, the company said.

Fetherman’s company has not yet revealed when he may be released from the hospital.

Fetterman suffered a stroke in a tense sprint in the final days of the primary campaign when he had a full schedule of trips and public events across the state.

While companies may slow down a bit in the weeks after the primaries, the company does not say whether this will affect Fetterman’s schedule or what visits to doctors or medications will be needed in the future.

Fetterman said the campaign itself “is not slowing down one step.”

Nothing else is changing. Fetterman remains in the race and on the ballot along with three other Democratic candidates.

In the race to replace retired Senator Pat Toomey, there are three politicians in Pennsylvania vying for senior positions: Lt. Gov. John Fetterman, Malcolm Kenyatta, and Connor Lamb. Hedge Fund CEO Dave McCormick and TV Chancellor Mehmet Oz are the main candidates in the Republican poll.

What is the diagnosis?

In a Sunday statement, Fetterman said he had a stroke that was caused by a heart clot that had been in the “A-fib rhythm for too long.” Doctors quickly and completely removed the clot, reversing the stroke, Fetterman said.

Blood can accumulate inside the heart pocket, allowing clots to form. The clots can then break off, get stuck and cut off the blood, often in the brain, which receives significant blood flow.

Fetterman did not say what method the doctors used to remove the clot. His company said its exact treatment regimen is still being developed, but will include short-term rest and a healthier diet.

Dr. Donald Lloyd-Jones, a cardiologist and chairman of the Department of Preventive Medicine at Northwestern University, said clots can be removed with drugs that “destroy clots” or, more often, by extracting the clot “mechanically” by inserting a catheter through artery in the groin.

The longer the clot blocks the artery, the more brain cells can die, so it is important to recognize stroke symptomssaid Lloyd-Jones, who is president of the American Heart Association and the American Stroke Association

According to Dr. Lloyd-Jones, people who develop A-fib almost always take blood-thinning drugs for the rest of their lives to prevent blood clots that cause stroke.

What is A-fib?

A-fibrillation – or atrial fibrillation – occurs when the upper chambers of the heart, called the atria, go out of sync with the pumping action of the lower chambers. This is a type of irregular heartbeat that is potentially severe but treatable.

In such an abnormal rhythm the upper chambers beat so fast that they cannot contract as usual. As a result, they do not move blood efficiently, so blood can stagnate in the upper chambers and form a clot, Lloyd-Jones said.

Sometimes patients experience tremors or palpitations, but many times they are unaware of the episode. Sometimes the heart returns to the rhythm on its own. Other patients receive an electric shock to return to rhythm.

A-fib causes 130,000 deaths and 750,000 hospitalizations a year in the U.S. 2% to 3% of adults in the U.S. at the age of Fetterman have suffered a stroke, and a significant number of them have caused atrial fibrillation, Lloyd-Jones said. .

How do doctors check for A-fib?

A-fib is most common in the elderly, and other risks include high blood pressure, sleep apnea, or a family history of arrhythmias. Obesity is also a significant risk factor, as is growth, Lloyd Jones said.

Fetterman’s height 6 feet 8, he has in the past openly talked about his desire to lose weight. He weighed over 400 pounds before losing almost 150 pounds in 2018.

Routine screening is not recommended for people without symptoms. Studies have not yet proven that early detection through screening will prevent enough strokes to outweigh the risks of unnecessary testing or over-treatment.